ApolloMed reported a strong Q4 2019 with a 68% increase in total revenue to $178.8 million and a net income of $6.7 million, driven by recent acquisitions and preferred dividends. The company manages over one million lives and is focused on scalable and profitable growth.
Total revenue increased by 68% to $178.8 million.
Capitation revenue increased by 92% to $148.6 million, representing 83% of total revenue.
Net income attributable to Apollo Medical Holdings, Inc. was $6.7 million, compared to a net loss of $3.1 million in the same quarter of the previous year.
The company entered into a new management services agreement effective January 1, 2020, covering approximately 145,000 members in Southern California.
For the year ending December 31, 2020, ApolloMed expects total revenue between $665.0 million and $675.0 million, net income between $20.0 million and $30.0 million, EBITDA between $55.0 million and $67.0 million, and Adjusted EBITDA between $75.0 million and $90.0 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance